Patient/advocate Diane Redington and Dr. Marcela del Carmen discuss diagnosis and treatment of gynecological carcinosarcoma (MMMT). This is part seven of a nine part series. Dr. Marcela del Carmen discusses how gynecological carcinosarcoma is different than ovarian or uterine cancers. It is very important to get an accurate diagnosis from an expert to confirm exactly […]
The second of two interviews conducted on January 5, 2017, with Diane Redington and Dr. Growdon on the topic of carcinosarcoma. This interview discusses: genomic analysis of carcinosarcoma, patterns of resistance, immunotherapy and clinical trials.
The following transcript is from an interview between Dr. Whitfield Growdon (MDC), a leading GYN Oncological Surgeon from Mass General Cancer Center in Boston and Diane Redington (DR), a woman with a Gynecological Carcinosarcoma (GCS) who is seeking to motivate researchers to advance the science and uncover knowledge about carcinosarcoma and find a cure for this cancer. This interview discusses diagnosis and treatment of MMMT.
An interview with Dr. Marcela del Carmen, leading GYN Oncologist, on the topic of GYN carcinosarcoma (also known MMMT) discussing diagnosis and treatment.
An interview with Sam Stern – fighter, thinker, and survivor Sam Stern has done many things. She was an accomplished criminal prosecutor, was and continues to be a practicing Buddhist and Vipassana meditation teacher, she’s the mother to two beautiful children, aged 16 and 20, and she was a mindfulness and pain management teacher to […]
Carcinosarcoma, or MMMT (malignant mixed Müllerian tumor), is an aggressive form of cancer affecting the female reproductive organs. It is difficult to detect in the early stages, grows rapidly, and may be resistant to chemotherapy and radiation. Nevertheless, many brave women have survived the battle against this rare cancer, and new breakthroughs in cancer treatments […]
The story of MMMT cancer is not a simple one. To start, the name “MMMT” is being replaced with the term “Carcinosarcoma”. While “Carcinosarcoma” is now considered standard, MMMT (or Malignant Mixed Müllerian Tumor) has a lengthy history within gynecological literature and is expected to continue to be used. MMMT is a rare cancer found in […]
Treatment is Highly Variable I have had the opportunity to speak with many women with GYN Carcinosarcoma including ovarian carcinosarcoma, uterine carcinosarcom and even one women with carcinosarcoma of the fallopian tube. One of the things I have learned is that there is a wide variation in how we are treated, as well as a broad variation […]
During a round table discussion on One Live TV, Michael J. Birrer, MD, PhD, explains new research for ovarian cancer in non-platinum-based chemotherapies, particularly PARP inhibition. Published on Apr 22, 2015.
In this video, Dr. Michael Birrer talks about targeting either VEGF or ANG2 in gynecologic cancers. VEGF stimulates tumor vessel growth, while ANG2 stabilizes the vessels. Published on Nov 25, 2015.